Lauren Pommert

Assistant Professor

University of Cincinnati

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Lauren Pommert is an Assistant Professor at the University of Cincinnati, located in the United States. Her research focuses on pediatric oncology, particularly the treatment and pharmacokinetics of chemotherapeutic agents in children with various cancers. Recent articles reflect her expertise in the clinical management of acute myeloid leukemia and non-Hodgkin lymphoma, as well as the inclusion of patients with Down syndrome in clinical trials.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

UNITED STATES

View details

Michael Burke

Associate Professor

Medical College of Wisconsin

UNITED STATES

View details

Jeremy Rubinstein

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Karen Chao

Clinical Assistant Professor

Stanford University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lauren Pommert

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors

A case of co‐occurring acute myeloid leukemia and relapsed diffuse large B‐cell lymphoma in a young adult with Shwachman–Diamond syndrome

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study

Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.

Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium

Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival

Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients with Acute Leukemia

Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium

Novel germline TRAF3IP3 mutation in a dyad with familial acute B lymphoblastic leukemia

Acute Leukemia in Infants

Collaborators (9)

Holly Lindsay

Zachary Taylor

Bill Chang

Vanessa Fabrizio

Akiko Shimamura

Eric S. Schafer

Michael Burke

Jeremy Rubinstein

Karen Chao

Make your next move.